Iceland· IS-650561 (IS)

Norgesic

A orphenadrin, kombinationen product containing paracetamolum inn,orphenadrinum inn cítrat, registered in Iceland by Viatris ApS. The same ATC class is registered in 4 of our 19 countries.

ATC M03BC51

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedNorgesicATCM03BC51REGISTER NO.IS-650561 (IS)PACKS LISTED2CHECKEDSeptember 8, 2026

Where it is registered

Orphenadrin, kombinationen is registered in 4 of 19 countries.

Countries holding a registration under ATC M03BC51 (orphenadrin, kombinationen), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 4 of them publish a price we can compare per daily dose

Orphenadrin, kombinationen · ATC M03BC51

4 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Icelandprice
  • Italyprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Paracetamolum INN,Orphenadrinum INN cítrat
Manufacturer
Viatris ApS
Country
Iceland (IS)
ATC code
M03BC51
ATC class
Orphenadrin, Kombinationen
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 8, 2026

Packs & prices · 2

2 priced
  • ean
    520759
    30 stk x1 þpakki
    ISK 2363
  • ean
    525014
    100 stk x1 þpakki
    ISK 3545

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Orphenadrin, kombinationen in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All orphenadrin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Austria · Norgesic
  • Cyprus · Unigesic
  • Finland · Norgesic
  • Greece · Norgesic, Unigesic
  • Malta · Norgesic, Unigesic
  • Sweden · Norgesic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cac05c94-3947-471a-897b-7d060d566c07
GET /v1/drugs/cac05c94-3947-471a-897b-7d060d566c07?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tafla",
  "source": "lyfjastofnun",
  "atc_raw": "M03BC51",
  "marketed": true,
  "strength": "35+450 mg",
  "ma_number": "650561 (IS)",
  "substance": "Paracetamolum INN,Orphenadrinum INN cítrat",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "24471"
}

See everything about orphenadrin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.